Blood flow in cervical and ovarian cancer
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study looks at how blood flow (perfusion) in cervical and ovarian tumors might relate to cancer outcomes. It aims to see if measuring blood flow can help predict how well patients respond to treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult woman.
- You have had a normal cervical smear in the last three years and no other gynecological cancers (for the control group).
- You have cervical cancer or precancerous lesions (for the cervical cancer group).
- You are suspected of having ovarian, fallopian tube, or peritoneal cancer before surgery (for the ovarian cancer group).
- You are able to undergo vaginal or abdominal 3D ultrasound scans.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a proactive approach to monitoring and managing blood flow during surgery for ovarian cancer, including a heated chemotherapy bath (HIPEC). It aims to improve recovery by keeping your blood pressure and circulation stable.
This trial tests if removing some blood before surgery and replacing it with fluids can reduce the need for transfusions in people with advanced ovarian cancer. It may help you have less blood loss during your operation.
This laboratory study uses ovarian cancer fluid collected during surgery to test possible new treatments on cancer and immune cells. It may help researchers find better treatment options in ovarian cancer.
This study uses ultrasound to look at how ovarian cancer affects the liver, helping doctors plan surgery better. By taking detailed pictures of the liver before surgery, they hope to improve outcomes for people with advanced or recurrent ovarian cancer.
This study is testing a new blood test to help find ovarian cancer early in women who are at average risk. By joining, you may help improve early detection, which could lead to better outcomes.
This study looks for cancer DNA in your blood to understand advanced ovarian cancer better. It helps doctors see how the disease changes over time and may improve future treatments.
Hear when a new Cervical Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.